Last reviewed · How we verify

NCT06092138

Edge Computing Platform for Spine Health Risk Management Based on IoT Technology

Completed NA Last updated 11 July 2025
What this trial tests

NA trial testing Wearable Device in Cervical Disc Herniation in 40 participants. Completed in 30 June 2025.

Timeline
20 October 2023
Primary endpoint
31 October 2024
30 June 2025

Quick facts

Lead sponsorXuanwu Hospital, Beijing
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date20 October 2023
Primary completion31 October 2024
Estimated completion30 June 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xuanwu Hospital, Beijing

Who can join

Adults 18 to 60, any sex, with Cervical Disc Herniation or Cervical Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project proposes to monitor the spinal posture of a person at rest and in motion in real time through a sensor device that contains spinal health monitoring as its core. By calibrating the five core planes on the spine and using AI algorithms to train the model, the relationship between the core plane data and spine health is established.This project will output medical-grade and consumer-grade wearable spine healthcare and monitoring products, establish an interactive platform to connect the wearer, the data terminal and the professional medical team, so that patients can easily get professional health advice and reminders during home healthcare and rehabilitation; and through the collection of spine health data, establish a national spine health database.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Wearable Device

Trials testing the same drug.

Other recruiting trials for Cervical Disc Herniation

Currently open trials in the same condition.

Other Xuanwu Hospital, Beijing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06092138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing